Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Crinetics Pharmaceuticals (CRNX) Leases (2019 - 2025)

Crinetics Pharmaceuticals (CRNX) has 7 years of Leases data on record, last reported at $40.5 million in Q4 2025.

  • For Q4 2025, Leases fell 6.93% year-over-year to $40.5 million; the TTM value through Dec 2025 reached $40.5 million, down 6.93%, while the annual FY2025 figure was $40.5 million, 6.93% down from the prior year.
  • Leases reached $40.5 million in Q4 2025 per CRNX's latest filing, down from $41.1 million in the prior quarter.
  • Across five years, Leases topped out at $48.0 million in Q3 2023 and bottomed at $1.3 million in Q2 2023.
  • Average Leases over 5 years is $22.8 million, with a median of $21.3 million recorded in 2021.
  • Peak YoY movement for Leases: decreased 26.16% in 2023, then surged 3492.18% in 2024.
  • A 5-year view of Leases shows it stood at $1.9 million in 2021, then fell by 21.46% to $1.5 million in 2022, then skyrocketed by 3032.5% to $46.5 million in 2023, then decreased by 6.54% to $43.5 million in 2024, then decreased by 6.93% to $40.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Leases were $40.5 million in Q4 2025, $41.1 million in Q3 2025, and $41.9 million in Q2 2025.